Defensive Positioning: Three Large-Cap Equities for Market Volatility

Investors are increasingly eyeing defensive strategies as high valuations and geopolitical tensions, specifically the ongoing conflict in Iran, raise concerns about a potential S&P 500 correction. While the index has gained approximately 2% this year, the risk of inflation-driven volatility remains a primary concern for portfolio managers. To mitigate this risk, analysts point to companies with robust fundamentals that historically decoupled from broader market trends. ExxonMobil, Eli Lilly, and Berkshire Hathaway are highlighted for their ability to outperform during the 2022 bear market, when the S&P 500 declined by more than 19%. ExxonMobil serves as a strategic hedge against rising energy costs, with oil prices recently exceeding $100 per barrel. The company has seen its stock rise approximately 24% in 2026 and offers a 2.8% dividend yield, significantly higher than the S&P 500 average of 1.2%. During the 2022 crash, XOM surged over 80%. In the healthcare sector, Eli Lilly is positioned for growth via its GLP-1 portfolio. Despite a 14% decline in share price this year, the company is launching Foundayo, a weight-loss pill that could act as a major catalyst. LLY previously rose 32% in 2022 following the approval of its diabetes treatment, Mounjaro. Finally, Berkshire Hathaway remains a staple for investors seeking safety through value investing. Under CEO Greg Abel, the firm continues its disciplined acquisition strategy. This approach allowed the company to post a modest 3% gain during the 2022 downturn, providing a buffer against systemic volatility.